Announcement of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s special report on the use and placement of fundraising during the first half of 2024.
Announcement of the Resolution of the Sixth Meeting of the Eighth Supervisory Committee of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Mid-year evaluation report of the 'Improving Efficiency and Returning More' action plan for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. in 2024.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Half-Year Report for 2024.
Announcement from Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. regarding the profit distribution plan for the mid-term of 2024.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Half-Yearly Report Summary 2024
Announcement from Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. regarding the 2024 interim performance presentation.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd voluntarily disclosed the announcement of completing the first subject enrollment in Phase I clinical trial for injection of FZ-AD005 antibody conjugate for the treatment of advanced solid tumors.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s annual equity distribution implementation announcement for 2023.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Announcement on the cancellation of part of the raised funds special account by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Rules of the Fudan-Zhangjiang Supervisory Board Meeting
Rules of Procedures of the Board of Directors of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Rules of the Shareholders Meeting of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s Articles of Association.
Announcement of resolutions from Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s 2023 Shareholders' Annual Meeting.
Legal Opinion Letter of Shanghai Fangda Law Firm on the Annual Shareholders' Meeting of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. in 2023.
No Data